Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$40.66 - $53.03 $18,988 - $24,765
-467 Reduced 43.6%
604 $50,000
Q1 2022

May 16, 2022

SELL
$59.95 - $92.06 $1.02 Million - $1.57 Million
-17,045 Reduced 94.09%
1,071 $77,000
Q4 2021

Feb 11, 2022

SELL
$81.07 - $121.29 $1.34 Million - $2.01 Million
-16,542 Reduced 47.73%
18,116 $1.47 Million
Q3 2021

Nov 12, 2021

SELL
$101.99 - $166.36 $155,738 - $254,031
-1,527 Reduced 4.22%
34,658 $4.03 Million
Q2 2021

Aug 13, 2021

BUY
$141.6 - $179.06 $2.45 Million - $3.1 Million
17,313 Added 91.74%
36,185 $6 Million
Q1 2021

May 14, 2021

SELL
$132.81 - $182.18 $10.8 Million - $14.9 Million
-81,624 Reduced 81.22%
18,872 $2.63 Million
Q4 2020

Feb 16, 2021

BUY
$138.17 - $184.34 $2.29 Million - $3.06 Million
16,609 Added 19.8%
100,496 $17.4 Million
Q3 2020

Nov 13, 2020

SELL
$114.09 - $145.51 $1.83 Million - $2.33 Million
-16,029 Reduced 16.04%
83,887 $11.7 Million
Q2 2020

Aug 11, 2020

BUY
$89.45 - $129.85 $2.8 Million - $4.07 Million
31,342 Added 45.71%
99,916 $11.9 Million
Q1 2020

May 15, 2020

SELL
$70.23 - $144.31 $3.05 Million - $6.26 Million
-43,362 Reduced 38.74%
68,574 $6.86 Million
Q4 2019

Feb 14, 2020

SELL
$76.41 - $117.54 $2.33 Million - $3.58 Million
-30,450 Reduced 21.39%
111,936 $13.2 Million
Q3 2019

Nov 14, 2019

SELL
$61.52 - $91.1 $611,262 - $905,169
-9,936 Reduced 6.52%
142,386 $12.2 Million
Q2 2019

Aug 14, 2019

BUY
$58.04 - $66.99 $8.84 Million - $10.2 Million
152,322 New
152,322 $9.88 Million
Q3 2018

Nov 15, 2018

SELL
$44.22 - $75.47 $1.62 Million - $2.76 Million
-36,548 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$72.38 - $92.5 $465,910 - $595,422
6,437 Added 21.38%
36,548 $2.92 Million
Q1 2018

May 11, 2018

SELL
$69.46 - $88.57 $253,459 - $323,191
-3,649 Reduced 10.81%
30,111 $2.61 Million
Q4 2017

Feb 15, 2018

BUY
$65.94 - $93.31 $645,025 - $912,758
9,782 Added 40.8%
33,760 $2.33 Million
Q3 2017

Nov 08, 2017

BUY
$80.87 - $91.08 $1.94 Million - $2.18 Million
23,978
23,978 $2.18 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.